Postoperative ileus after digestive surgery: Network meta-analysis of pharmacological intervention.

abdominal surgery digestive surgery ileus network meta-analysis pharmacology postoperative complication postoperative ileus

Journal

British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323

Informations de publication

Date de publication:
09 Aug 2023
Historique:
revised: 15 07 2023
received: 28 03 2023
accepted: 18 07 2023
pubmed: 10 8 2023
medline: 10 8 2023
entrez: 10 8 2023
Statut: aheadofprint

Résumé

Several medicinal treatments for avoiding postoperative ileus (POI) after abdominal surgery have been evaluated in randomized controlled trials (RCTs). This network meta-analysis aimed to explore the relative effectiveness of these different treatments on ileus outcome measures. A systematic literature review was performed to identify RCTs comparing treatments for POI following abdominal surgery. A Bayesian network meta-analysis was performed. Direct and indirect comparisons of all regimens were simultaneously compared using random-effects network meta-analysis. A total of 38 RCTs were included in this network meta-analysis reporting on 6371 patients. Our network meta-analysis shows that prokinetics significantly reduce the duration of first gas (mean difference [MD] = 16 h; credible interval -30, -3.1; surface under the cumulative ranking curve [SUCRA] 0.418), duration of first bowel movements (MD = 25 h; credible interval -39, -11; SUCRA 0.25) and duration of postoperative hospitalization (MD -1.9 h; credible interval -3.8, -0.040; SUCRA 0.34). Opioid antagonists are the only treatment that significantly improve the duration of food recovery (MD -19 h; credible interval -26, -14; SUCRA 0.163). Based on our meta-analysis, the 2 most consistent pharmacological treatments able to effectively reduce POI after abdominal surgery are prokinetics and opioid antagonists. The absence of clear superiority of 1 treatment over another highlights the limits of the pharmacological principles available.

Identifiants

pubmed: 37559444
doi: 10.1111/bcp.15878
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.

Références

Venara A, Meillat H, Cotte E, et al. Incidence and risk factors for severity of postoperative ileus after colorectal surgery: a prospective registry data analysis. World J Surg. 2020;44:957-966.
Chapman SJ, Pericleous A, Downey C, Jayne DG. Postoperative ileus following major colorectal surgery. Br J Surg. 2018;105:797-810.
Solanki S, Chakinala RC, Haq KF, et al. Paralytic ileus in the United States: a cross-sectional study from the national inpatient sample. SAGE Open Med. 2020;8:2050312120962636.
Boeckxstaens GE, de Jonge WJ. Neuroimmune mechanisms in postoperative ileus. Gut. 2009;58:1300-1311.
Buscail E, Deraison C. Postoperative ileus: a pharmacological perspective. Br J Pharmacol. 2022;179(13):3283-3305. doi:10.1111/bph.15800
Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777-784. doi:10.7326/M14-2385
Cochrane Handbook for Systematic Reviews of Interventions. https://training.cochrane.org/handbook
Chapman SJ, Lee MJ, Blackwell S, et al. Establishing core outcome sets for gastrointestinal recovery in studies of postoperative ileus and small bowel obstruction: protocol for a nested methodological study. Colorectal Dis. 2020;22(4):459-464. doi:10.1111/codi.14899
Chapman SJ, Thorpe G, Vallance AE, et al. Systematic review of definitions and outcome measures for return of bowel function after gastrointestinal surgery. BJS Open. 2019;3(1):1-10. doi:10.1002/bjs5.102
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13. doi:10.1186/1471-2288-5-13
Dechartres A, Altman DG, Trinquart L, Boutron I, Ravaud P. Association between analytic strategy and estimates of treatment outcomes in meta-analyses. JAMA. 2014;312:623-630.
Nuesch E, Trelle S, Reichenbach S, et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ. 2010;341(jul16 1):c3515. doi:10.1136/bmj.c3515
Chen J-Y, Ko TL, Wen YR, et al. Opioid-sparing effects of ketorolac and its correlation with the recovery of postoperative bowel function in colorectal surgery patients: a prospective randomized double-blinded study. Clin J Pain. 2009;25(6):485-489. doi:10.1097/AJP.0b013e31819a506b
Silinsky JD, Marcet JE, Anupindi VR, et al. Preoperative intravenous meloxicam for moderate-to-severe pain in the immediate post-operative period: a phase IIIb randomized clinical trial in 55 patients undergoing primary open or laparoscopic colorectal surgery with bowel resection and/or anastomosis. Pain Manag. 2021;11(1):9-21. doi:10.2217/pmt-2020-0061
Sim R, Cheong DM, Wong KS, Lee BMK, Liew QY. Prospective randomized, double-blind, placebo-controlled study of pre- and postoperative administration of a COX-2-specific inhibitor as opioid-sparing analgesia in major colorectal surgery. Colorectal Dis. 2007;9:52-60.
Xu Y, Tan Z, Chen J, Lou F, Chen W. Intravenous flurbiprofen axetil accelerates restoration of bowel function after colorectal surgery. Can J Anaesth. 2008;55:414-422.
Rizvanović N, Nesek Adam V, Čaušević S, Dervišević S, Delibegović S. A randomised controlled study of preoperative oral carbohydrate loading versus fasting in patients undergoing colorectal surgery. Int J Colorectal Dis. 2019;34:1551-1561.
Cvetkovic A, Kalezic N, Milicic B, et al. The impact of different infusion solutions on postoperative recovery following colorectal surgery. J BUON. 2018;23(5):1369-1379.
Zhang T, Xu Y, Yao Y, et al. Randomized controlled trial: perioperative dexamethasone reduces excessive postoperative inflammatory response and ileus after surgery for inflammatory bowel disease. Inflamm Bowel Dis. 2021;27(11):1756-1765. doi:10.1093/ibd/izab065
Lightfoot AJ, Eno M, Kreder KJ, O'Donnell MA, Rao SSC, Williams RD. Treatment of postoperative ileus after bowel surgery with low-dose intravenous erythromycin. Urology. 2007;69(4):611-615. doi:10.1016/j.urology.2006.12.027
Smith AJ, Nissan A, Lanouette NM, et al. Prokinetic effect of erythromycin after colorectal surgery: randomized, placebo-controlled, double-blind study. Dis Colon Rectum. 2000;43(3):333-337. doi:10.1007/BF02258298
Biondo S, Miquel J, Espin-Basany E, et al. A double-blinded randomized clinical study on the therapeutic effect of Gastrografin in prolonged postoperative ileus after elective colorectal surgery. World J Surg. 2016;40(1):206-214. doi:10.1007/s00268-015-3260-9
Vather R, Josephson R, Jaung R, Kahokehr A, Sammour T, Bissett I. Gastrografin in prolonged postoperative ileus: a double-blinded randomized controlled trial. Ann Surg. 2015;262(1):23-30. doi:10.1097/SLA.0000000000001062
Büchler MW, Seiler CM, Monson JRT, et al. Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study. Aliment Pharmacol Ther. 2008;28(3):312-325. doi:10.1111/j.1365-2036.2008.03696.x
Delaney CP, Weese JL, Hyman NH, et al. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery. Dis Colon Rectum. 2005;48(6):1114-1125. discussion 1125-1126; author reply 1127-1129. doi:10.1007/s10350-005-0035-7
Ludwig K, Enker WE, Delaney CP, et al. Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway. Arch Surg. 2008;143(11):1098-1105. doi:10.1001/archsurg.143.11.1098
Taguchi A, Sharma N, Saleem RM, et al. Selective postoperative inhibition of gastrointestinal opioid receptors. N Engl J Med. 2001;345(13):935-940. doi:10.1056/NEJMoa010564
Viscusi ER, Goldstein S, Witkowski T, et al. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study. Surg Endosc. 2006;20(1):64-70. doi:10.1007/s00464-005-0104-y
Viscusi ER, Rathmell JP, Fichera A, et al. Randomized placebo-controlled study of intravenous methylnaltrexone in postoperative ileus. J Drug Assess. 2013;2(1):127-134. doi:10.3109/21556660.2013.838169
Wolff BG, Michelassi F, Gerkin TM, et al. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus. Ann Surg. 2004;240(4):728-734. discussion 734-735. doi:10.1097/01.sla.0000141158.27977.66
Beck DE, Sweeney WB, McCarter MD, McCarter MD, Ipamorelin 201 Study Group. Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis. 2014;29(12):1527-1534. doi:10.1007/s00384-014-2030-8
Bochicchio G, Charlton P, Pezzullo JC, Kosutic G, Senagore A. Ghrelin agonist TZP-101/ulimorelin accelerates gastrointestinal recovery independently of opioid use and surgery type: covariate analysis of phase 2 data. World J Surg. 2012;36:39-45.
Brown TA, McDonald J, Williard W. A prospective, randomized, double-blinded, placebo-controlled trial of cisapride after colorectal surgery. Am J Surg. 1999;177:399-401.
Chan D-C, Liu YC, Chen CJ, et al. Preventing prolonged post-operative ileus in gastric cancer patients undergoing gastrectomy and intra-peritoneal chemotherapy. World J Gastroenterol. 2005;11(31):4776-4781. doi:10.3748/wjg.v11.i31.4776
Cheape JD, Wexner SD, James K, Jagelman DG. Does metoclopramide reduce the length of ileus after colorectal surgery? A prospective randomized trial. Dis Colon Rectum. 1991;34:437-441.
Davidson ED, Hersh T, Brinner RA, Barnett SM, Boyle LP. The effects of metoclopramide on postoperative ileus. A randomized double-blind study. Ann Surg. 1979;190:27-30.
Falkén Y, Webb DL, Abraham-Nordling M, Kressner U, Hellström PM, Näslund E. Intravenous ghrelin accelerates postoperative gastric emptying and time to first bowel movement in humans. Neurogastroenterol Motil. 2013;25(6):474-480. doi:10.1111/nmo.12098
Gong J, Xie Z, Zhang T, et al. Randomised clinical trial: prucalopride, a colonic pro-motility agent, reduces the duration of post-operative ileus after elective gastrointestinal surgery. Aliment Pharmacol Ther. 2016;43(7):778-789. doi:10.1111/apt.13557
Hallerbäck B, Carlsen E, Carlsson K, et al. Beta-adrenoceptor blockade in the treatment of postoperative adynamic ileus. Scand J Gastroenterol. 1987;22(2):149-155. doi:10.3109/00365528708991872
Herzog T, Lemmens HP, Arlt G, et al. Treatment of postoperative ileus with choline citrate-results of a prospective, randomised, placebo-controlled, double-blind multicentre trial. Int J Colorectal Dis. 2011;26(5):645-652. doi:10.1007/s00384-010-1092-5
Narita K, Tsunoda A, Takenaka K, Watanabe M, Nakao K, Kusano M. Effect of mosapride on recovery of intestinal motility after hand-assisted laparoscopic colectomy for carcinoma. Dis Colon Rectum. 2008;51(11):1692-1695. doi:10.1007/s10350-008-9407-0
Park HE, Kim MK, Kang W-K. Efficacy and safety of ramosetron injection for nausea and vomiting in colorectal-cancer patients undergoing a laparoscopic colectomy: a randomized, double-blind, comparative study. Ann Coloproctol. 2018;34:36-41.
Popescu I, Fleshner PR, Pezzullo JC, Charlton PA, Kosutic G, Senagore AJ. The ghrelin agonist TZP-101 for management of postoperative ileus after partial colectomy: a randomized, dose-ranging, placebo-controlled clinical trial. Dis Colon Rectum. 2010;53(2):126-134. doi:10.1007/DCR.0b013e3181b54166
Shaw M, Pediconi C, McVey D, et al. Safety and efficacy of ulimorelin administered postoperatively to accelerate recovery of gastrointestinal motility following partial bowel resection: results of two randomized, placebo-controlled phase 3 trials. Dis Colon Rectum. 2013;56(7):888-897. doi:10.1097/DCR.0b013e31829196d0
Stakenborg N, Labeeuw E, Gomez-Pinilla PJ, et al. Preoperative administration of the 5-HT4 receptor agonist prucalopride reduces intestinal inflammation and shortens postoperative ileus via cholinergic enteric neurons. Gut. 2019;68(8):1406-1416. doi:10.1136/gutjnl-2018-317263
Toyomasu Y, Mochiki E, Morita H, et al. Mosapride citrate improves postoperative ileus of patients with colectomy. J Gastrointest Surg. 2011;15(8):1361-1367. doi:10.1007/s11605-011-1567-x
Zingg U, Miskovic D, Pasternak I, Meyer P, Hamel CT, Metzger U. Effect of bisacodyl on postoperative bowel motility in elective colorectal surgery: a prospective, randomized trial. Int J Colorectal Dis. 2008;23(12):1175-1183. doi:10.1007/s00384-008-0536-7
Folwarski M, Dobosz M, Małgorzewicz S, Skonieczna-Żydecka K, Kaźmierczak-Siedlecka K. Effects of lactobacillus rhamnosus GG on early postoperative outcome after pylorus-preserving pancreatoduodenectomy: a randomized trial. Eur Rev Med Pharmacol Sci. 2021;25:397-405.
Rodríguez-Padilla Á, Morales-Martín G, Pérez-Quintero R, Gómez-Salgado J, Balongo-García R, Ruiz-Frutos C. Postoperative ileus after stimulation with probiotics before ileostomy closure. Nutrients. 2021;13(2):626. doi:10.3390/nu13020626
Yang Y, Xia Y, Chen H, et al. The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial. Oncotarget. 2016;7(7):8432-8440. doi:10.18632/oncotarget.7045
Benson MJ, Roberts JP, Wingate DL, et al. Small bowel motility following major intra-abdominal surgery: the effects of opiates and rectal cisapride. Gastroenterology. 1994;106(4):924-936. doi:10.1016/0016-5085(94)90751-X
Hedrick TL, McEvoy M, Mythen MMG, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on postoperative gastrointestinal dysfunction within an enhanced recovery pathway for elective colorectal surgery. Anesth Analg. 2018;126(6):1896-1907. doi:10.1213/ANE.0000000000002742
Isola S, Hussain A, Dua A, Singh K, Adams N. Metoclopramide. In: StatPearls. StatPearls Publishing; 2021.
Traut U, Brügger L, Kunz R, et al. Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adults. Cochrane Database Syst Rev. 2008;(1):CD004930. doi:10.1002/14651858.CD004930.pub3
Becker G, Blum HE. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus. Lancet. 2009;373:1198-1206.
Schang JC, Hémond M, Hébert M, Pilote M. How does morphine work on colonic motility? An electromyographic study in the human left and sigmoid colon. Life Sci. 1986;38:671-676.
Tonin FS, Rotta I, Mendes AM, Pontarolo R. Network meta-analysis: a technique to gather evidence from direct and indirect comparisons. Pharm Pract (Granada). 2017;15:943.

Auteurs

Etienne Buscail (E)

Digestive Surgery Department, Toulouse University Hospital, Toulouse, France.
INSERM, U1220, University of Toulouse, Digestive Health Research Institute (IRSD), Toulouse, France.

Thibault Planchamp (T)

INSERM, U1220, University of Toulouse, Digestive Health Research Institute (IRSD), Toulouse, France.
Paediatric Surgery Department, Toulouse University Hospital, Toulouse, France.

Guillaume Le Cosquer (G)

INSERM, U1220, University of Toulouse, Digestive Health Research Institute (IRSD), Toulouse, France.
Gastroenterology Department, Toulouse University Hospital, Toulouse, France.

Manon Bouchet (M)

Digestive Surgery Department, Toulouse University Hospital, Toulouse, France.

Julie Thevenin (J)

INSERM, U1220, University of Toulouse, Digestive Health Research Institute (IRSD), Toulouse, France.

Nicolas Carrere (N)

Digestive Surgery Department, Toulouse University Hospital, Toulouse, France.

Fabrice Muscari (F)

Digestive Surgery Department, Toulouse University Hospital, Toulouse, France.

Olivier Abbo (O)

Paediatric Surgery Department, Toulouse University Hospital, Toulouse, France.

Charlotte Maulat (C)

Digestive Surgery Department, Toulouse University Hospital, Toulouse, France.

Ariane Weyl (A)

Gynaecological Surgery Department, Toulouse University Hospital, Toulouse, France.

Jean Pierre Duffas (JP)

Digestive Surgery Department, Toulouse University Hospital, Toulouse, France.

Antoine Philis (A)

Digestive Surgery Department, Toulouse University Hospital, Toulouse, France.

Laurent Ghouti (L)

Digestive Surgery Department, Toulouse University Hospital, Toulouse, France.

Cindy Canivet (C)

Digestive Surgery Department, Toulouse University Hospital, Toulouse, France.
Gastroenterology Department, Toulouse University Hospital, Toulouse, France.

Jean Paul Motta (JP)

INSERM, U1220, University of Toulouse, Digestive Health Research Institute (IRSD), Toulouse, France.

Nathalie Vergnolle (N)

INSERM, U1220, University of Toulouse, Digestive Health Research Institute (IRSD), Toulouse, France.

Celine Deraison (C)

INSERM, U1220, University of Toulouse, Digestive Health Research Institute (IRSD), Toulouse, France.

Jason Shourick (J)

Epidemiology and Public Health Department, UMR 1027 INSERM, Toulouse University Hospital, University of Toulouse, Toulouse, France.

Classifications MeSH